SARS-CoV-2 Mpro protease variants of concern display altered viral and host target processing but retain potency towards antivirals
S. A. Chen, E. Arutyunova, J. Lu, M. B. Khan, W. Rut, M. Zmudzinski, S. Shahbaz, J. Iyyathurai, E. Moussa, Z. Turner, B. Bai, T. Lamer, J. A. Nieman, J. C. Vederas, O. Julien, , M. J. Lemieux
The paper examines how SARS-CoV-2 Mpro variants affect viral and host protein processing but maintain antiviral potency.
bioRxiv · Jan 28, 2023 · PreprintBiochemistry